Evidence map›Paper›PMID 41282000›Full record

ReviewFrontiers in medicine2025

Surgical management of chronic Stevens-Johnson syndrome.

Aastha Garg, Abha Gour, Nidhi Chauhan, Mehak Sapra, Virender Singh Sangwan

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aastha GargDepartment of Cornea & Anterior Segment, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Abha GourDepartment of Cornea & Anterior Segment, Centre for Unknown and Rare Eye Diseases, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Nidhi ChauhanDepartment of Cornea & Anterior Segment, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Mehak SapraEicher Shroff Centre for Stem Cell Research, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
Virender Singh SangwanDepartment of Cornea & Anterior Segment, Centre for Unknown and Rare Eye Diseases, Dr. Shroff's Charity Eye Hospital, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stevens-Johnson Syndrome (SJS) is a rare but severe mucocutaneous disorder that often leads to chronic ocular complications, requiring a comprehensive and multidisciplinary approach to management. This review outlines the pathophysiology and long-term ocular sequelae of SJS and discusses evidence-based strategies for stabilizing the ocular surface and restoring visual function. Key interventions include punctal occlusion to address tear film instability, mucous membrane grafting (MMG) for lid margin reconstruction, and amniotic membrane transplantation (AMT) to promote epithelial healing and reduce inflammation. Cultivated oral mucosal epithelial transplantation (COMET) and minor salivary gland transplantation (MSGT) serve as advanced options for restoring ocular surface function in severe cases. The correction of cicatricial entropion, often seen in chronic SJS, involves techniques such as anterior lamellar repositioning with or without grafting, which restore lid alignment and reduce ocular trauma. Visual rehabilitation through cataract surgery or keratoprosthesis demands careful preoperative planning due to the fragile ocular surface and heightened risk of postoperative complications. A tailored, staged management plan focused on surface preservation, structural correction, and visual restoration is essential to improve outcomes and quality of life for patients with chronic ocular SJS.

Indexed as

amniotic membrane transplantationcataract surgeryCOMETkeratoprosthesismucous membrane graftingocular surface stabilisationpunctal occlusionStevens-Johnson syndrome

Identifiers

PMID41282000
PMCPMC12634522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.